AUSTIN, 08 JULY 2026: OriGen Biomedical, a leading provider of cryopreservation and cell culture products, is excited to announce the relocation of its headquarters to a new, state-of-the-art facility in Austin, Texas. This strategic move supports the company’s ongoing growth and commitment to delivering exceptional service and innovative solutions to its customers worldwide.
The new facility, located at 2215 Grand Avenue Parkway, spans 81,000 square feet and is designed to support OriGen’s expanding operations. The space features two custom-built clean rooms, a sterile fill suite, dedicated office spaces, and technology to improve efficiency, quality, and customer experience. These enhancements will enable OriGen to streamline manufacturing processes and respond more effectively to the growing demand for its single-use disposable solutions in the cell therapy industry.
“We are thrilled to announce our move to this new facility,” said Beth San Segundo, President & CEO of OriGen Biomedical. “This relocation represents a significant milestone for our company. It reflects our commitment to continuous improvement, growth, and, most importantly, providing our customers with high-quality products and responsive service. With these new resources, we’re poised to meet the needs of an evolving industry and to continue supporting advancements in patient care.”
OriGen’s operations at 7000 Burleson Rd., Bldg D, Austin, TX 78744 are in the process of transitioning to the new headquarters. The new facility is operational, and teams are actively moving functions in phases to ensure continuity. This carefully managed transition is designed to be seamless, with no disruption to customer orders or support services. During the facility transition period, OriGen Biomedical® products and some documents may display either the Burleson or Grand Avenue Parkway address as existing inventory is depleted and updated labeling is implemented.
The expanded headquarters and manufacturing facility highlight OriGen Biomedical’s dedication to innovation, quality, and excellence, further establishing its position as a trusted leader in the cryopreservation and cell culture industry.
ABOUT ORIGEN BIOMEDICAL
OriGen Biomedical, Inc. is a leading producer of cryopreservation and cell culture products. Our focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. OriGen Biomedical® products are designed with the patient and user in mind, and we strive to maintain excellent customer service to ensure that patient care is the priority. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention that it will improve patient health. Founded in 1997 and headquartered in Austin, Texas, OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. To learn more visit www.origen.com and follow us on LinkedIn and X.
CONTACT:
Kirsten Krupps – Senior Marketing Manager
OriGen Biomedical, Inc.
k.krupps@origenbio.com
512-474-7278
